Vertex Pharmaceuticals (VRTX) P/E ratio history
Above its usual range
As of
VRTX's P/E of 30.6x is higher than 79% of its available weekly readings from the last five years.
Share P/E history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
P/E at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | P/E | 5-year rank |
|---|---|---|
| 31.8× | 94% | |
| Unavailable | Short history | |
| 30.6× | 82% | |
| 22.8× | 27% | |
| 26.4× | 40% | |
| 23.1× | 21% | |
| 26.4× | 29% | |
| 69.1× | 7% | |
| 192.1× | 90% | |
| Unavailable | Short history |
Loading related research…
About this history
- What is VRTX's current P/E?
- VRTX's P/E of 30.6x is higher than 79% of its available weekly readings from the last five years.
- What is VRTX's five-year median P/E?
- The median, or middle weekly reading, is 28.2× over the last five years. Available history contains 818 weekly observations from Feb 21, 2011 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.